Relay Therapeutics, Inc. (RLAY) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Relay Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -5.25x | -1.74x | -3.95x | -5.77x | -8.03x | -71.41x |
| P/B Ratio | 2.56x | 0.76x | 1.79x | 1.76x | 3.25x | 4.90x |
| P/S Ratio | 94.54x | 58.82x | 52.83x | 1214.17x | 964.56x | 45.28x |
| Profitability | ||||||
| Gross Margin | 76.8% | 100.0% | 100.0% | 100.0% | 100.0% | 95.7% |
| Operating Margin | -1971.6% | -3722.1% | -1460.1% | -21670.9% | -12040.2% | -67.5% |
| Net Margin | -1800.6% | -3374.7% | -1338.7% | -21036.1% | -12012.9% | -63.4% |
| EBITDA Margin | -1777.4% | -3799.4% | -1464.6% | -22217.4% | -7364.9% | -63.2% |
| Liquidity | ||||||
| Current Ratio | 22.61x | 15.95x | 25.44x | 16.00x | 40.14x | 56.49x |
| Quick Ratio | 22.61x | 15.95x | 25.44x | 15.81x | 40.14x | 56.49x |
| Leverage | ||||||
| Debt/Equity | 0.06x | 0.06x | 0.07x | 0.06x | 0.03x | 0.03x |
YoY = year-over-year change. Source: FMP..